ReviewImmunoTargets and therapy2025
Prostate Cancer Immunotherapy: Time to Move Beyond Checkpoint Inhibitors.
Melissa Abel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it
ReviewImmunoTargets and therapy2025
Melissa Abel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.